Monday, August 31, 2026

Skyworks Solutions Stock Bullish Momentum With A 12.84% Rise Today

ViaNews Editorial Team

February 7, 2023

Skyworks Solutions Stock Bullish Momentum With A 12.84% Rise Today

(VIANEWS) - The NASDAQ ended the session with Skyworks Solutions (SWKS) jumping 12.84% to $123.31 on Tuesday while NASDAQ jumped 1.9% to $12,113.79.

Skyworks Solutions's last close was $109.28, 25.06% below its 52-week high of $145.82.

About Skyworks Solutions

Skyworks Solutions, Inc., together with its subsidiaries, designs, develops, manufactures, and markets proprietary semiconductor products, including intellectual property in the United States, China, South Korea, Taiwan, Europe, the Middle East, Africa, and rest of Asia-Pacific. Its product portfolio includes amplifiers, antenna tuners, attenuators, automotive tuners and digital radios, circulators/isolators, DC/DC converters, demodulators, detectors, diodes, wireless analog system on chip products, directional couplers, diversity receive modules, filters, front-end modules, hybrids, light emitting diode drivers, low noise amplifiers, mixers, modulators, optocouplers/optoisolators, phase locked loops, phase shifters, power dividers/combiners, receivers, switches, synthesizers, timing devices, technical ceramics, voltage controlled oscillators/synthesizers, and voltage regulators. The company provides its products for use in the aerospace, automotive, broadband, cellular infrastructure, connected home, entertainment and gaming, industrial, medical, military, smartphone, tablet, and wearable markets. It sells its products through direct sales force, electronic component distributors, and independent sales representatives. The company was incorporated in 1962 and is headquartered in Irvine, California.

Earnings Per Share

As for profitability, Skyworks Solutions has a trailing twelve months EPS of $7.22.

PE Ratio

Skyworks Solutions has a trailing twelve months price to earnings ratio of 17.07. Meaning, the purchaser of the share is investing $17.07 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.24%.

Volatility

Skyworks Solutions's last week, last month's, and last quarter's current intraday variation average was 0.50%, 1.09%, and 2.11%.

Skyworks Solutions's highest amplitude of average volatility was 1.69% (last week), 1.96% (last month), and 2.11% (last quarter).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Aug 23, 2022, the estimated forward annual dividend rate is 2.48 and the estimated forward annual dividend yield is 2.96%.

Yearly Top and Bottom Value

Skyworks Solutions's stock is valued at $123.31 at 17:06 EST, way below its 52-week high of $145.82 and way higher than its 52-week low of $76.16.

Sales Growth

Skyworks Solutions's sales growth for the current quarter is 6.8%.

More news about Skyworks Solutions (SWKS).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com